Evaluating the impact of GLP-1 receptor agonists on weight management in patients with breast cancer undergoing endocrine therapy: A comparative analysis. A phase II trial of anlotinib and fulvestrant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback